|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61N 1/05 | (2006.01) |
| A61B 18/1477 | (2013.01) | ||
| A61N 1/04 | (2006.01) | ||
| A61N 1/327 | (2013.01) | ||
| A61B 18/14 | (2006.01) | ||
| A61B2018/00577 | (2013.01) |
| (11) | Patento numeris | 3077041 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14868104.2 |
| Europos patento paraiškos padavimo data | 2014-12-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/068774 |
| Data | 2014-12-05 |
| (87) | Numeris | WO 2015/085162 |
| Data | 2015-06-11 |
| (30) | Numeris | Data | Šalis |
| 201361912172 P | 2013-12-05 | US | |
| 201414451333 | 2014-08-04 | US |
| (72) |
ONIK, Gary, M. , US
MIESSAU, James, A. , US
|
| (73) |
Rfemb Holdings LLC ,
P.O. Box 66, North Branford, CT 06471,
US
|
| (54) | CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) |
| CANCER IMMUNOTHERAPY BY RADIOFREQUENCY ELECTRICAL MEMBRANE BREAKDOWN (RF-EMB) |